| 1 |
中华医学会呼吸病学分会，中国医师协会呼吸医师分会. 中国成人2019冠状病毒病的诊治与防控指南[J]. 中华医学杂志，2021, 101(18): 1293-1356.
|
| 2 |
Alangaden GJ, Thyagarajan R, Gruber SA, et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors[J]. Clin Transplant, 2006, 20(4): 401-409.
|
| 3 |
Boubenider S, Hiesse C, Marchand S, et al. Post-transplant polyomavirus infections[J]. J Nephrol, 1999, 12(1): 24-29.
|
| 4 |
Hartmann A, Sagedal S, Hjelmesaeth J. The natural course of cytomegalovirus infection and disease in renal transplant recipients[J]. Transplantation, 2006, 82(2 Suppl): S15-S17.
|
| 5 |
马晓旭，臧素华，楚伟丽，等. 肾移植术后新型冠状病毒肺炎二例诊疗体会[J]. 中华器官移植杂志，2020, 41(4): 207-211.
|
| 6 |
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention[J]. JAMA, 2020, 323(13): 1239-1242.
|
| 7 |
Li LQ, Huang T, Wang YQ, et al. COVID-19 patients′ clinical characteristics, discharge rate, and fatality rate of meta-analysis[J]. J Med Virol, 2020, 92(6): 577-583.
|
| 8 |
Rampal L, Liew BS, Choolani M, et al. Battling COVID-19 pandemic waves in six South-East Asian countries: A real-time consensus review[J]. Med J Malaysia, 2020, 75(6): 613-625.
|
| 9 |
Osmanodja B, Mayrdorfer M, Halleck F, et al. Undoubtedly, kidney transplant recipients have a higher mortality due to COVID-19 disease compared to the general population[J]. Transpl Int, 2021, 34(5): 769-771.
|
| 10 |
陈松，张伟杰，陈刚，等．新型冠状病毒感染器官移植受者临床诊疗及移植工作的指导意见(第一版)[J]. 中华器官移植杂志，2020, 41(3): 136-139.
|
| 11 |
Sagedal S, Nordal KP, Hartmann A, et al. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients[J]. Am J Transplant, 2002, 2(9): 850-856.
|
| 12 |
Asberg A, Humar A, Rollag H, et al. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients[J]. Am J Transplant, 2007, 7(9): 2106-2113.
|
| 13 |
关文达，杜秋伶，江海明，等. 阿比多尔与连花清瘟胶囊对中东呼吸综合征冠状病毒的体内外抑制作用比较[J]. 广东医学，2018, 39(23): 3454-3458.
|
| 14 |
Chu CM, Cheng VCC, Hung IF, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings[J]. Thorax, 2004, 59(3): 252-256.
|
| 15 |
Randhawa P, Brennan DC. BK virus in transplant recipients: An overview and update[J]. Am J Transplant, 2006, 6(9): 2000-2005.
|
| 16 |
詹嘉铭，王祥慧. 注射用免疫球蛋白在肾脏移植中的应用进展[J]. 上海交通大学学报(医学版), 2012, 32(8): 1092-1096.
|
| 17 |
Aziz F, Muth B, Parajuli S, et al. Unusually high rates of acute rejection during the COVID-19 pandemic: cause for concern？[J]. Kidney Int, 2020, 98(2): 513-514.
|
| 18 |
Shinn C, Malhotra D, Chan L, et al. Time course of response to pulse methylprednisolone therapy in renal transplant recipients with acute allograft rejection[J]. Am J Kidney Dis, 1999, 34(2): 304-307.
|